II
RMD icon

Inspire Investing’s ResMed RMD Stock Holding History

Inspire Investing’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78M Buy
9,119
+1,308
+17% +$271K 0.07% 297
2026
Q1 		$1.75M Buy
7,811
+6,909
+766% +$1.72M 0.1% 224
2025
Q4 		$217K Buy
902
+66
+8% +$16.9K 0.02% 831
2025
Q3 		$229K Sell
836
-18,061
-96% -$4.93M 0.02% 831
2025
Q2 		$4.88M Sell
18,897
-9,681
-34% -$2.31M 0.53% 33
2025
Q1 		$6.4M Buy
28,578
+6,472
+29% +$1.51M 0.76% 20
2024
Q4 		$5.06M Sell
22,106
-485
-2% -$117K 0.57% 30
2024
Q3 		$5.51M Buy
22,591
+1,204
+6% +$269K 0.56% 29
2024
Q2 		$4.09M Buy
21,387
+3,185
+17% +$646K 0.47% 40
2024
Q1 		$3.6M Buy
18,202
+916
+5% +$168K 0.37% 58
2023
Q4 		$2.97M Buy
17,286
+1,486
+9% +$228K 0.33% 64
2023
Q3 		$2.34M Sell
15,800
-2,441
-13% -$441K 0.3% 73
2023
Q2 		$3.99M Sell
18,241
-1,450
-7% -$323K 0.48% 42
2023
Q1 		$4.31M Buy
19,691
+1,722
+10% +$374K 0.55% 34
2022
Q4 		$3.74M Buy
17,969
+1,470
+9% +$323K 0.48% 36
2022
Q3 		$3.6M Sell
16,499
-690
-4% -$157K 0.51% 34
2022
Q2 		$3.6M Sell
17,189
-2,335
-12% -$497K 0.48% 39
2022
Q1 		$4.74M Sell
19,524
-434
-2% -$105K 0.55% 32
2021
Q4 		$5.2M Buy
19,958
+1,629
+9% +$423K 0.6% 35
2021
Q3 		$4.83M Buy
18,329
+15,704
+598% +$4.29M 0.61% 33
2021
Q2 		$647K Buy
+2,625
New +$552K 0.09% 240
2021
Q1 		– Sell
-1,610
Closed -$342K – 710
2020
Q4 		$342K Sell
1,610
-2,417
-60% -$482K 0.08% 373
2020
Q3 		$690K Buy
+4,027
New +$744K 0.19% 119
2020
Q2 		– Sell
-470
Closed -$69K – 669
2020
Q1 		$69K Buy
+470
New +$74.9K 0.03% 530
2018
Q1 		– Sell
-687
Closed -$58K – 594
2017
Q4 		$58K Buy
+687
New +$56.8K 0.05% 411

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Inspire Investing's RMD Position: Q2 2026 in Review

Inspire Investing increased its ResMed (RMD) stake by 17% in Q2 2026, buying an estimated $271K and bringing the position to 9,119 shares worth $1.78M. The position accounts for 0.07% of the portfolio, ranked #297.

Inspire Investing first reported a position in RMD in Q4 2017 and has held it in 25 quarters since. The position peaked at $6.4M in Q1 2025. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Inspire Investing held 9,119 shares of ResMed worth $1.78M as of Q2 2026.
  • Inspire Investing bought 1,308 ResMed shares in Q2 2026, an estimated $271K.
  • ResMed made up 0.07% of Inspire Investing's portfolio in Q2 2026, its #297 holding.
  • Inspire Investing first reported a position in ResMed in Q4 2017 and has held it in 25 quarters since.
  • Inspire Investing's ResMed position peaked at $6.4M in Q1 2025.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.